Duration of Dual Antiplatelet Therapy After Drug-eluting Stents Implantation: The Jury Is Still Out

Rev Esp Cardiol (Engl Ed). 2015 Oct;68(10):827-9. doi: 10.1016/j.rec.2015.03.015. Epub 2015 Jun 26.

Authors

Stefanie Schulz-Schüpke¹, Adnan Kastrati²

Affiliations

¹ Deutsches Herzzentrum München, Technische Universität, Munich, Germany; DZHK, Partner Site Munich Heart Alliance, Munich, Germany.
² Deutsches Herzzentrum München, Technische Universität, Munich, Germany; DZHK, Partner Site Munich Heart Alliance, Munich, Germany. Electronic address: kastrati@dhm.mhn.de.

PMID: 26118900
DOI: 10.1016/j.rec.2015.03.015

No abstract available

Publication types

Editorial
Comment

MeSH terms

Aspirin
Drug Therapy, Combination
Drug-Eluting Stents*
Humans
Platelet Aggregation Inhibitors / therapeutic use
Ticlopidine / therapeutic use*
Time Factors
Treatment Outcome

Substances

Platelet Aggregation Inhibitors
Ticlopidine
Aspirin